Subdermal Contraceptive Implants Market Trends

  • Report ID: 5300
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT

Subdermal Contraceptive Implants Market - Growth Drivers and Challenges

Growth Drivers

  • Rising Awareness about Family Planning – As a result, the demand for subdermal contraceptive implants is expected to rise as they have a huge potential to help in family planning, and are one of the most practical, accessible, and increasingly accepted forms of family planning in the world. Globally, more than 60% percent of married women between the ages of 15 and 49 practice family planning.
  • Increasing Knowledge about Contraceptives- Educational interventions across the globe are helping to increase the knowledge of available contraceptive methods, which has led to an increase in the adoption of subdermal contraceptive implants as an acceptable means of contraception for adolescent girls and young women.

Challenges

  • Side Effects of Subdermal Contraceptive Implants- There are a few side effects that some people experience after receiving implants which include menstrual irregularities, headaches, weight gain, acne, dizziness, mood swings, nausea, lower abdominal pain, hair loss, loss of libido, pain at the implant site, neuropathy, and follicular cysts.

Additionally, implanon (etonogestrel) a contraceptive used to prevent pregnancy can cause serious eye symptoms, serious heart symptoms, and severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination. Furthermore, it should not be used at the time of pregnancy as it can lead to a certain serious pregnancy issue (ectopic pregnancy).

  • Lack of Awareness in Developing Regions
  • Lack of Skilled Professionals to Insert and Remove these Implants

Base Year

2025

Forecast Year

2026-2035

CAGR

3.7%

Base Year Market Size (2025)

USD 1.11 billion

Forecast Year Market Size (2035)

USD 1.6 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of subdermal contraceptive implants is assessed at USD 1.15 billion.

The global subdermal contraceptive implants market size was valued at around USD 1.11 billion in 2025 and is projected to grow at a CAGR of more than 3.7%, reaching USD 1.6 billion revenue by 2035.

North America is predicted to hold the largest share of 55% by 2035, impelled by the widespread availability of contraceptive implants such as Nexplanon.

Key players in the market include Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos